Panaitescu Anca Maria, Ciobanu Anca Marina, Popa Maria, Duta Irina, Gica Nicolae, Peltecu Gheorghe, Veduta Alina
Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Filantropia Clinical Hospital, 11171 Bucharest, Romania.
Medicina (Kaunas). 2021 Apr 15;57(4):381. doi: 10.3390/medicina57040381.
Gestational diabetes mellitus (GDM) is recognized as one of the most common medical complications of pregnancy that can lead to significant short-term and long-term risks for the mother and the fetus if not detected early and treated appropriately. Current evidence suggests that, with the use of appropriate screening programs for GDM, those women diagnosed and treated have reduced perinatal morbidity. It has been implied that, when screening for GDM, there should be uniformity in the testing used and in further management. This paper summarizes and compares current screening strategies proposed by international bodies and discusses application in the context of the COVID-19 pandemic.
妊娠期糖尿病(GDM)被认为是妊娠最常见的医学并发症之一,如果不及早发现并进行适当治疗,可能会给母亲和胎儿带来重大的短期和长期风险。目前的证据表明,通过使用适当的GDM筛查方案,那些被诊断并接受治疗的女性围产期发病率会降低。有人认为,在筛查GDM时,所使用的检测方法和进一步的管理应保持一致。本文总结并比较了国际机构提出的当前筛查策略,并讨论了在2019冠状病毒病大流行背景下的应用。